Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit
Journal of the American Geriatrics Society
Fecha de publicación: 21 January 2019
DOI: https://doi.org/10.1111/jgs.15751
Autores: Noll L. Campbell PharmD, MS., Anthony J. Perkins MS., Babar A. Khan MD, MS., Sujuan Gao PhD., Mark O. Farber MD., Sikandar Khan MD, MS.
Background: Benzodiazepines and anticholinergics are risk factors for delirium in the intensive care unit (ICU). We tested the impact of a deprescribing intervention on short‐term delirium outcomes.
